LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk-Reference-Cited by-同舟云学术

LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk

Published:2018-07-13 Issue:2 Volume:104 Page:235-238
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Ofori-Asenso Richard¹²,Zoungas Sophia³,Tonkin Andrew⁴,Liew Danny¹

Affiliation:

1. Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Australia

2. Epidemiological Modelling Unit, Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Australia

3. Division of Metabolism, Genomics and Ageing, Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Australia

4. Cardiovascular Research Unit, Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1125/fullpdf

Reference10 articles.

1. Novel biomarkers for cardiovascular risk prediction;Wang;J. Geriatr. Cardiol.,2017

2. A century of cholesterol and coronaries: from plaques to genes to statins;Goldstein;Cell,2015

3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

4. Reliability of calculated low-density lipoprotein cholesterol;Meeusen;Am. J. Cardiol.,2015

5. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Cholesterol Treatment Trialists, C.;Lancet,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of probiotic modulation of ovarian sex hormone production and metabolism: a review;Food & Function;2024

2. Long-lasting Control of LDL-Cholesterol Induces a Forty Percent Reduction in the Incidence of Cardiovascular Events:New Insights from a 7-year Study;Journal of Pharmacology and Experimental Therapeutics;2023-09-29

3. Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification;Value in Health;2023-04

4. Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care;Journal of Clinical Lipidology;2022-07

5. Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia;Current Problems in Cardiology;2021-11